The Advisory Board Company (ABCO) was Downgraded by KeyBanc Capital Mkts to ” Sector Weight”. Earlier the firm had a rating of “Overweight ” on the company shares. KeyBanc Capital Mkts advised their investors in a research report released on Apr 18, 2016.
Many Wall Street Analysts have commented on The Advisory Board Company. Shares were Upgraded by Deutsche Bank on Feb 25, 2016 to ” Buy” and Lowered the Price Target to $ 43 from a previous price target of $53 .Shares were Downgraded by FBR Capital on Feb 24, 2016 to ” Mkt Perform” and Lowered the Price Target to $ 40 from a previous price target of $55 .Shares were Downgraded by Robert W. Baird on Feb 24, 2016 to ” Neutral” and Lowered the Price Target to $ 40 from a previous price target of $60 .
On the company’s financial health, The Advisory Board Company reported $0.48 EPS for the quarter, beating the analyst consensus estimate by $ 0.18 according to the earnings call on Feb 23, 2016. Analyst had a consensus of $0.30. The company had revenue of $205.00 million for the quarter, compared to analysts expectations of $207.35 million. The company’s revenue was up 37.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.26 EPS.
The Advisory Board Company opened for trading at $31.84 and hit $33.46 on the upside on Friday, eventually ending the session at $33.05, with a gain of 3.77% or 1.2 points. The heightened volatility saw the trading volume jump to 2,82,571 shares. Company has a market cap of $1,374 M.
In a different news, on Mar 22, 2016, Hoose Mary Van (Chief Talent Officer) sold 4,172 shares at $30.27 per share price. According to the SEC, on Mar 16, 2016, Cormac F Miller (Chief Product Officer) sold 1,624 shares at $28.75 per share price. On Jan 15, 2016, Richard A Schwartz (President) sold 4,000 shares at $57.14 per share price, according to the Form-4 filing with the securities and exchange commission.
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.